Completing data — refresh the page later to see the latest
490-83-5O=C1O[C@H]([C@@H](O)CO)C(=O)C1=OSBJKKFFYIZUCET-JLAZNSOCSA-NL-dehydroascorbic acid is dehydroascorbic acid having the L-configuration. It has a role as a coenzyme and a mouse metabolite. It is a dehydroascorbic acid and a vitamin C. It is functionally related to a L-ascorbic acid. It is a conjugate acid of a L-dehydroascorbate.
490-83-5127.8 Ų [M-H]- [CCS Type: DT; Method: single field calibrated with ESI Low Concentration Tuning Mix (Agilent)]
128.2 Ų [M-H]-
Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
Warning
H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]
P264, P270, P301+P317, P330, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 62 reports by companies from 1 notifications to the ECHA C&L Inventory.
Chemical: L-threo-2,3-Hexodiulosonic acid, .gamma.-lactone
L-threo-2,3-Hexodiulosonic acid, .gamma.-lactone: Does not have an individual approval but may be used under an appropriate group standard
Dehydroascorbic acid has similar biological activity as ascorbic acid. Both compounds have been shown to have antiviral effects against herpes simplex virus type 1, influenza virus type A and poliovirus type 1 with dehydroascorbic acid having the stronger effect. In addition, unlike ascorbic acid, dehydroascorbic acid can cross the blood brain barrier and is then converted to ascorbic acid to enable retention in the brain. This is important because one study has found that after an ischemic stroke, dehydroascorbic acid has neuroprotective effects by reducing infarct volume, neurological deficits, and mortality.
Even though dehydroascorbic acid and ascorbic acid have similar effects, their mechanism of action seems to be different. The exact mechanism of action is still being investigated, but some have been elucidated. Concerning dehydroascorbic acid's antiviral effect against herpes simplex virus type 1, it is suggested that dehydroascorbic acid acts after replication of viral DNA and prevents the assembly of progeny virus particles.
UsesThe reversibly oxidized form of ascorbic acid.
DTXSID00912316CHEMBL174035CHEBI:27956DefinitionChEBI: Dehydroascorbic acid having the L-configuration.